John T. Treace, Chief Executive Officer at TREACE MEDICAL CONCEPTS, INC. (TMCI), sold 5,253,805 shares at $17.00 ($89.3M) on 2021-04-27, disclosed to the SEC on 2021-04-29.
Open-market sale of $89.3M TMCI by Chief Executive Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| Filing → |
| TMCI | BUY | 2026-06-11 | $211K | — | Filing → |
| TMCI | BUY | 2026-06-01 | $178K | — | Filing → |
| TMCI | BUY | 2026-05-28 | $341K | — | Filing → |